Differential Behavior of Coagulation Factor XIII in Patients with Inflammatory Bowel Disease and in Patients with Giant Cell Arteritis

Publisher： Karger

E-ISSN： 1424-8840|29|6|326-335

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.29, Iss.6, 2000-06, pp. : 326-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coagulation and Fibrinolysis in Inflammatory Bowel Disease and in Giant Cell Arteritis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 75-83

Karger

Access to resources Recommend Favorite

Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 3, 2015-03 ,pp. : 390-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

Frequency and Characteristics of Pancreatitis in Patients with Inflammatory Bowel Disease

By  

Pancreatology, Vol. 6, Iss. 5, 2006-10 ,pp. : 464-471

Karger

Access to resources Recommend Favorite

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1154-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelets and Anticoagulant Capacity in Patients with Inflammatory Bowel Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 92-96

Karger

Access to resources Recommend Favorite